Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

100%(3 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_3

75%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

3(75.0%)

Phase 4Post-market surveillance

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 33 (75.0%)

Phase 41 (25.0%)

Trials by Status

terminated125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_3

Ibuprofen Sodium Tension Headache Study

NCT01362491

terminatedphase_4

Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates

NCT00961753

completedphase_3

Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache

NCT01077973

completedphase_3

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

NCT01098747

Clinical Trials (4)

Showing 4 of 4 trials

NCT01362491Phase 3

Ibuprofen Sodium Tension Headache Study

Completed

NCT00961753Phase 4

Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates

Terminated

NCT01077973Phase 3

Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache

Completed

NCT01098747Phase 3

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4